FDA Approves New Pet Medication Tablet Sizes

New pet medication tablets approved by FDA.

The U.S. Food and Drug Administration has approved two new sizes of Bayer Animal Health’s Drontal (praziquantel and pyrantel pamoate) pet medication tablets, which are used in pet cats and kittens for the removal of various internal parasites.

Available sizes now include:

• 13.6 mg praziquantel and 54.3 mg pyrantel base (as pyrantel pamoate)
• 18.2 mg praziquantel and 72.6 mg pyrantel base (as pyrantel pamoate)
• 27.2 mg praziquantel and 108.6 mg pyrantel base (as pyrantel pamoate)

Revised pet medication dosing requirements are as follows: “Administer a minimum dose of 2.27 mg praziquantel and 9.2 mg pyrantel pamoate per pound of body weight according to the dosing tables on labeling. May be given directly by mouth or in a small amount of food. Do not withhold food prior to or after treatment. If reinfection occurs, treatment may be repeated.”

The FDA has also revised the kitten age and weight restriction for the drug. The labeling now indicates that Drontal Tablets are not for use in kittens less than two months of age or weighing less than 2 pounds.

The label previously said not for use in kittens less than one month of age or weighing less than 1.5 pounds.Bayer Animal Health is based in Shawnee Mission, Kan.


Leave a Comment


Your email address will not be published. Required fields are marked *


Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.